Lisa Graver

Lisa Graver

Director Ejecutivo en ALVOTECH .

Fortuna: 130 794 $ al 31/07/2026

55 años
Health Technology
Consumer Services
Commercial Services

Perfil

Currently, Lisa Graver is Chief Executive Officer at Norwich Pharmaceuticals, Inc., Chief Executive Officer at Alvotech starting in 2026, and Director at Alvotech hf.
Formerly, Ms. Graver was Chief Executive Officer at Alvogen, Inc. from 2010 to 2025, Chief Executive Officer at Alvogen Pharma US, Inc., Senior Director & VP-Intellectual Property at Actavis, Inc. from 2006 to 2008, Associate at Kirkland & Ellis LLP, and President at Almaject, Inc. Education includes undergraduate studies at the University of Lakehead and graduate studies at Case Western Reserve University School of Law.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
ALVOTECH
0,01 %
06/03/2026 31.746 ( 0,01 % ) 130 794 $ 31/07/2026

Cargos activos de Lisa Graver

EmpresasCargoInicio
ALVOTECH Director Ejecutivo 01/03/2026
Director Ejecutivo -
Director/Miembro de la Junta -

Antiguos cargos conocidos de Lisa Graver.

EmpresasCargoFin
Director Ejecutivo 01/12/2025
Director Ejecutivo 01/12/2025
Corporate Officer/Principal 01/01/2008
Presidente -
Corporate Officer/Principal -
Ver el detalle de la experiencia de Lisa Graver.

Formación de Lisa Graver.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

53

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas10

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology